Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Equillium Inc
(NQ:
EQ
)
1.020
-0.020 (-1.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
68,862
Open
1.050
Bid (Size)
0.7701 (6)
Ask (Size)
0.9958 (4)
Prev. Close
1.040
Today's Range
1.010 - 1.090
52wk Range
0.4500 - 3.250
Shares Outstanding
34,414,149
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference
Today 8:00 EDT
From
Equillium, Inc.
Via
Business Wire
EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q2 2024
August 09, 2024
EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
+38.91%
+38.91%
1 Month
+29.39%
+29.39%
3 Month
-26.09%
-26.09%
6 Month
-60.77%
-60.77%
1 Year
+27.50%
+27.50%
More News
Read More
Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights
August 08, 2024
From
Equillium Inc.
Via
Business Wire
Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
August 06, 2024
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance
July 18, 2024
From
Equillium, Inc.
Via
Business Wire
Equillium to Participate in Upcoming Investor Conferences
July 02, 2024
From
Equillium, Inc.
Via
Business Wire
Equillium to be included in the Russell Microcap® Index
June 12, 2024
From
Equillium, Inc.
Via
Business Wire
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 05, 2024
From
Equillium, Inc.
Via
Business Wire
Dow Surges 200 Points; Designer Brands Shares Plunge Following Q1 Earnings
June 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 04, 2024
Via
Benzinga
Nano-Cap Equillium Shares Fall After Patchy Hair Loss Study Data
June 04, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 04, 2024
Via
Benzinga
Gold Down 1%; Bath & Body Works Shares Tumble After Q1 Results
June 04, 2024
Via
Benzinga
US Stocks Lower; Donaldson Earnings Beat Views
June 04, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata
June 04, 2024
From
Equillium Inc.
Via
Business Wire
Equillium to Present at the Jefferies Global Healthcare Conference
May 29, 2024
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease
May 14, 2024
From
Equillium, Inc.
Via
Business Wire
EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
May 09, 2024
From
Equillium Inc.
Via
Business Wire
Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
May 07, 2024
From
Equillium, Inc.
Via
Business Wire
Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 03, 2024
From
Equillium, Inc.
Via
Business Wire
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
April 01, 2024
From
Equillium, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 26, 2024
Via
Benzinga
EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q4 2023
March 25, 2024
Via
InvestorPlace
Why Westport Fuel Systems Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 26, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.